# ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

> **NCT07270666** · NA · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **GENETIC:** ctDNA Testing
- **OTHER:** Blood draw

## Key facts

- **NCT ID:** NCT07270666
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-25
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07270666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07270666, "ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07270666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*